NL7212176A - - Google Patents

Info

Publication number
NL7212176A
NL7212176A NL7212176A NL7212176A NL7212176A NL 7212176 A NL7212176 A NL 7212176A NL 7212176 A NL7212176 A NL 7212176A NL 7212176 A NL7212176 A NL 7212176A NL 7212176 A NL7212176 A NL 7212176A
Authority
NL
Netherlands
Application number
NL7212176A
Other versions
NL162072B (nl
NL162072C (nl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7212176A publication Critical patent/NL7212176A/xx
Publication of NL162072B publication Critical patent/NL162072B/xx
Application granted granted Critical
Publication of NL162072C publication Critical patent/NL162072C/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/36Compounds containing oxirane rings with hydrocarbon radicals, substituted by nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/08Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/16Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/753Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22Bridged ring systems
    • C07D221/28Morphinans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/02Ortho- or ortho- and peri-condensed systems
    • C07C2603/04Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/22Ortho- or ortho- and peri-condensed systems containing three rings containing only six-membered rings
    • C07C2603/26Phenanthrenes; Hydrogenated phenanthrenes
NL7212176.A 1971-09-08 1972-09-07 Werkwijze voor het bereiden van pijnstillende, anti- -narcotische geneesmiddelen, aldus verkregen gevormde geneesmiddelen,alsmede werkwijze voor het bereiden van daarvoor geschikte actieve stoffen. NL162072C (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17883771A 1971-09-08 1971-09-08
US00217633A US3819635A (en) 1971-09-08 1972-01-13 14-hydroxymorphinan derivatives

Publications (3)

Publication Number Publication Date
NL7212176A true NL7212176A (xx) 1973-03-12
NL162072B NL162072B (nl) 1979-11-15
NL162072C NL162072C (nl) 1980-04-15

Family

ID=26874723

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7212176.A NL162072C (nl) 1971-09-08 1972-09-07 Werkwijze voor het bereiden van pijnstillende, anti- -narcotische geneesmiddelen, aldus verkregen gevormde geneesmiddelen,alsmede werkwijze voor het bereiden van daarvoor geschikte actieve stoffen.

Country Status (19)

Country Link
US (1) US3819635A (xx)
JP (1) JPS5310596B2 (xx)
AU (1) AU470102B2 (xx)
BE (1) BE788478A (xx)
CA (1) CA999578A (xx)
CH (1) CH590845A5 (xx)
CY (1) CY980A (xx)
DD (1) DD100255A5 (xx)
DE (3) DE2265256C2 (xx)
DK (1) DK141624B (xx)
FR (1) FR2154481B1 (xx)
GB (2) GB1412129A (xx)
HK (1) HK2679A (xx)
IE (2) IE36687B1 (xx)
KE (1) KE2911A (xx)
MY (1) MY7900027A (xx)
NL (1) NL162072C (xx)
SE (2) SE398877B (xx)
YU (1) YU45099B (xx)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3910920A (en) * 1973-11-07 1975-10-07 Bristol Myers Co 3,14,17-Substituted-6,7-tetramethylenemorphinans
US3980641A (en) * 1975-07-31 1976-09-14 Bristol-Myers Company Process for the preparation of 14-hydroxymorphinans
US4017497A (en) * 1975-11-18 1977-04-12 Bristol-Myers Company Process for the preparation of 14-hydroxymorphinan derivatives
US4139534A (en) * 1977-02-17 1979-02-13 Bristol-Myers Company Process for the preparation of 14-hydroxymorphinan derivatives
JPS52136176A (en) * 1976-03-23 1977-11-14 Bristol Myers Co Method of improving 144hydroxymorphinan derivatives
US4058531A (en) * 1976-03-23 1977-11-15 Bristol-Myers Company Process for the preparation of 14-hydroxymorphinan derivatives
US4052389A (en) * 1976-03-23 1977-10-04 Bristol-Myers Company Derivatives of 9,10-dihydroxy-1-(p-alkoxybenzyl)-perhydroisoquinoline oxazine-3-one
GB1593191A (en) * 1977-03-23 1981-07-15 Reckitt & Colmann Prod Ltd Derivatives of morphine
GB1587831A (en) * 1977-03-23 1981-04-08 Reckitt & Colmann Prod Ltd Morphine derivatives
US4115389A (en) * 1977-05-02 1978-09-19 Bristol-Myers Company Process of N-demethylating (-)-1-(p-methoxybenzyl)-2-methyl-1,2,3,4,5,6,7,8-octahydroisoquinoline
US4338320A (en) * 1978-11-15 1982-07-06 The Board Of Regents Of The University Of Nebraska Esters of 6'-hydroxycinchonine, and a method of treating arrythmia with them
US4228285A (en) * 1979-02-28 1980-10-14 Bristol-Myers Company 14-Hydroxy-6-oxamorphinans and 14-hydroxy-6-oxaisomorphinans
US4272540A (en) * 1979-04-24 1981-06-09 Sisa, Incorporated 14-Methoxymorphinan-6-one compounds and therapeutic methods of treating pain and drug dependence with them
US4322427A (en) * 1981-04-16 1982-03-30 Bristol-Myers Company Analgetic compositions and methods of use
EP0661283B1 (en) * 1993-07-19 1998-10-21 Toray Industries, Inc. Brain cell protective
NZ268969A (en) * 1993-07-23 1997-06-24 Toray Industries Morphinan derivatives and pharmaceutical compositions
CZ281174B6 (cs) * 1993-08-13 1996-07-17 Galena, A.S. Způsob přípravy 3,14ß-dihydroxy-17-normorfinanu
AU753278B2 (en) 1998-02-25 2002-10-10 Abbott Laboratories Butorphanol sustained release formulations
US20040167164A1 (en) * 1998-05-05 2004-08-26 Jose Pozuelo Compositions and methods for treating particular chemical addictions and mental illnesses
EP2987788A1 (en) 2002-05-17 2016-02-24 Taiwanj Pharmaceuticals Co., Ltd. Opioid and opioid-like compounds and uses thereof
US7923454B2 (en) 2002-05-17 2011-04-12 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
US7501433B2 (en) * 2002-05-17 2009-03-10 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
US8017622B2 (en) * 2003-05-16 2011-09-13 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
CN103073496B (zh) * 2013-02-18 2015-08-26 苏州立新制药有限公司 右美沙芬的制备方法
ES2750853T3 (es) 2014-10-14 2020-03-27 Hisamitsu Pharmaceutical Co Parche adhesivo

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3166559A (en) * 1965-01-19 J-lower alkoxy-x-phenyloxy-ix-hydroxy-
GB1028407A (en) * 1962-04-06 1966-05-04 Shionogi & Co Improvements in or relating to morphinan derivatives and their preparation
FR1362540A (fr) * 1963-04-05 1964-06-05 Shionogi & Co Dérivés n substitués du morphinane et leur production

Also Published As

Publication number Publication date
GB1412129A (en) 1975-10-29
DE2265256C2 (de) 1985-10-24
DK141624B (da) 1980-05-12
FR2154481A1 (xx) 1973-05-11
DE2265255C2 (de) 1986-06-05
IE36687L (en) 1973-03-08
US3819635A (en) 1974-06-25
HK2679A (en) 1979-01-19
NL162072B (nl) 1979-11-15
JPS4834864A (xx) 1973-05-22
YU227772A (en) 1982-02-28
MY7900027A (en) 1979-12-31
DK141624C (xx) 1980-10-13
IE36688B1 (en) 1977-02-02
YU45099B (sh) 1992-07-20
AU470102B2 (en) 1976-03-04
JPS5310596B2 (xx) 1978-04-14
DE2265256A1 (de) 1977-01-27
SE398877B (sv) 1978-01-23
SE7506292L (sv) 1975-06-02
AU4622872A (en) 1974-03-07
DE2243961C2 (xx) 1988-07-21
CY980A (en) 1979-03-23
SE403286B (sv) 1978-08-07
DE2243961A1 (de) 1973-04-05
KE2911A (en) 1979-01-26
NL162072C (nl) 1980-04-15
CH590845A5 (xx) 1977-08-31
CA999578A (en) 1976-11-09
BE788478A (fr) 1973-03-06
GB1412130A (en) 1975-10-29
DD100255A5 (xx) 1973-09-12
IE36687B1 (en) 1977-02-02
FR2154481B1 (xx) 1976-04-23
DE2265255A1 (de) 1977-01-27

Similar Documents

Publication Publication Date Title
DK141624C (xx)
ATA136472A (xx)
AU2658571A (xx)
AU2485671A (xx)
AU2684071A (xx)
AU2564071A (xx)
AU2577671A (xx)
AR199640Q (xx)
AU2503871A (xx)
AU2473671A (xx)
AU2415871A (xx)
AU2588771A (xx)
AR192311Q (xx)
AU2456871A (xx)
AU2940971A (xx)
AU2486471A (xx)
AR202997Q (xx)
AU2654071A (xx)
AU1109576A (xx)
AU2399971A (xx)
AU2930871A (xx)
AU2669471A (xx)
AU2455871A (xx)
CH1446071A4 (xx)
BG26667A3 (xx)

Legal Events

Date Code Title Description
V4 Discontinued because of reaching the maximum lifetime of a patent